AndreaBozzo/ceres-open-data-index huggingface dataset:
Receipt of Services for Behavioral Health Problems: Results from the 2014 National Survey on Drug Use and Health

This report is the third (in a series of four) regarding the First Release Reports for the 2014 NSDUH.  This report presents data from the 2002 through 2014 NSDUHs for substance use treatment and mental health service use among people aged 12 or older. Results are presented for adolescents aged 12 to 17 and for adults aged 18 or older. Where trends are presented, the report focuses on long-term trends by comparingestimates from the 2014 NSDUH with comparable estimates in 2002 to 2013 (or in 2008 to 2013 for some estimates of mental health service use). Statistically significant differences are noted between estimates in 2014 and those in prior years.
Compound 526741: 2-Decyloxyethanol, TMS

Chemical compound data from PubChem database. IUPAC Name: 2-decoxyethoxy(trimethyl)silane. Molecular Formula: C15H34O2Si. Molecular Weight: 274.51. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401695-T1: [Translated] CONTROL OF POWER RATIOS FOR IN-PHASE AND QUADRATURE CHANNELS IN A COMMUNICATIONS SYSTEM

A transmitter in a radiocommunications system such as a Wideband Code Division Multiple Access (WCDMA) communications system transmits one set of data on an in-phase (I-) channel and another set of data on a quadrature (Q-) channel. The transmitter generates a gain signal, ², and multiplies the digital data associated with the Q-channel by the gain signal, ². Complexity of the multiplication operation is reduced by limiting the gain signal, ², to a finite number of values that are exactly representable by a predefined number of bits, such as 4-bit values to the right of a binary radix point. Modulation inaccuracy associated with quantization of ² can be eliminated by utilizing the same quantized values of ² in all components within the radiocommunications system.
Compound 530531: 5-Chlorovaleric acid, octadecyl ester

Chemical compound data from PubChem database. IUPAC Name: octadecyl 5-chloropentanoate. Molecular Formula: C23H45ClO2. Molecular Weight: 389.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527209: 2-(8,8a-Dimethyl-1,3,4,6,7,8-hexahydronaphthalen-2-ylidene)propan-1-ol

Chemical compound data from PubChem database. IUPAC Name: 2-(8,8a-dimethyl-1,3,4,6,7,8-hexahydronaphthalen-2-ylidene)propan-1-ol. Molecular Formula: C15H24O. Molecular Weight: 220.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Neuroendocrine effects of inhaling emissions generated by 3-dimensional (3D)-printing with polycarbonate stock

Inhalation of emissions (particulate and volatile chemicals) generated while 3-dimensional (3D) printing with polycarbonate feedstock generates respirable bisphenol A (BPA). BPA is a known endocrine disruptor that affects both reproductive and metabolic endocrine function.   A previous study examining the effects of exposure to a lower dose of emissions from 3D printing (3DE, dose approximately 600 µg/m3) found changes that were consistent with other studies reporting the effects of ingesting BPA.
Compound 525042: 3',4'-Dichloroenanthoanilide

Chemical compound data from PubChem database. IUPAC Name: N-(3,4-dichlorophenyl)heptanamide. Molecular Formula: C13H17Cl2NO. Molecular Weight: 274.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401271-T1: [Translated] CONVEYING DEVICE FOR OBJECTS OF SOLID OR GEL-LIKE CONSISTENCY AND METHOD FOR PROMOTING SUCH OBJECTS

The sorter for pharmaceutical tablets or pills (9) comprises a rotating drum (110) mounted at an angle to the horizontal, so that the tablets collect at its lower wall. They then fall though a hole in its base (111) and are held (6, 7) between this and a lower plate (130) as the drum rotates until they reach a cut-out section in it,, when they fall out (8) of the sorter.
DEV DQS Prescription drug use in the past 30 days, by sex, race and Hispanic origin, and age group: United States

Data on prescription drug use in the past 30 days in the United States, by sex, race and Hispanic origin, and age group. Data are from Health, United States. SOURCE: National Center for Health Statistics, National Health and Nutrition Examination Survey.
Search, visualize, and download these and other estimates from over 120 health topics with the NCHS Data Query System (DQS), available from: https://www.cdc.gov/nchs/dataquery/index.htm.
Compound 529172: 1-Pentanamine, mono-DMTBS

Chemical compound data from PubChem database. IUPAC Name: N-[tert-butyl(dimethyl)silyl]pentan-1-amine. Molecular Formula: C11H27NSi. Molecular Weight: 201.42. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Managed Care Institutional Provider Network Data: December 31, 2012

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. 

This dataset reflects institutional provider data.
Provider Network Data System information is self reported. For more information, go to http://www.health.ny.gov/health_care/managed_care/.
Fluticasone propionate and salmeterol

Wixela Inhub is a prescription inhaler combining fluticasone propionate (a corticosteroid to reduce inflammation) and salmeterol (a long-acting bronchodilator to open airways). It's used to treat asthma and chronic obstructive pulmonary disease (COPD) in adults and some children. Inhale as directed by your doctor. This information was generated using AI and is provided for informational and research purposes only.
Doxazosin

Cardura (doxazosin mesylate) is a prescription medication used to treat high blood pressure and symptoms of an enlarged prostate. It comes as oral tablets in strengths of 1 mg, 2 mg, 4 mg, and 8 mg, manufactured by Viatris. This alpha-blocker helps relax blood vessels and muscles in the prostate. This information was generated using AI and is provided for informational and research purposes only.
Patent AT-E40082-T1: [Translated] ELECTRONIC DEVICE FOR THE CONTROL OF AN ASSEMBLY CONSISTING OF A DIESEL ENGINE DRIVING A GENERATOR WHICH IN turn FEED AN ELECTRIC MOTOR.

The inventive control system introduces the current ( DELTA I) and voltage ( DELTA C) deviations simultaneously with the injection set point (C) to define a new injection set point (C') that is utilized in conjunction with the measurement of diesel engine speed (VrD) to adjust the injection and with the measurement of the injection flow rate Cr to adjust the generator excitation current.
Patent AT-E399745-T1: [Translated] METHOD FOR CONSOLIDATION OF ORNAMENTAL STONES AND RELEVANT INSTALLATION

The method for consolidating plate-like, slice-like or modularelement-like ornamental stones comprises: the impregnation by means of the pressure created in the treatment environment with a water glass solution wherein the material being treated is plunged for enough time for the full penetration in fissures and microporosities of the surface thereof; characterised in that it has the following steps:-A pre-treatment of the material by exhausting;-A permanence of the pre-treatment step for enough time to extract gases, steams and powders existing in said fissures and microporosities;-An injection of the impregnating solution with a water glass solution and keeping the treatment chamber under vacuum during the injection and in the following impregnation step. The absolute pre-treatment pressure is preferably of 0.2-0.3 mbar; for the injection it is preferably between 10 and 100 mbar, while for the impregnation it is preferably kept at a pressure close to the steam pressure of the water glass solution being used. The implant being used and the device for the stowage and handling of the materials to be treated are also described.
Patent AT-E401486-T1: [Translated] ROTATING AND SLIDING PLATE SUPPORT ARRANGEMENT

A device for pivotable and slidable suspension of sheets, such as window-panes for glazed verandas or balconies. The device has an upper and a lower rail, which are arranged in parallel with each other. The rails have transversely of their longitudinal direction a hollow section with a longitudinal slot on the side facing the other rail. On each of the sheets, an upper and a lower fixing element are arranged, which via the slots engage the rails. The lower fixing element has in its lowermost portion a spherical part which rests against a sliding surface in the lower rail section to enable both a sliding and a pivoting motion. Both the upper and the lower fixing element are cylindrical in the portion which extends through the slot in each rail.
COVID-19 State Profile Report - Indiana

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
CD26 immuno-expression and periodontal disease progression

Immunological mechanisms participate in the pathogenesis of human chronic inflammatory periodontal disease (CIPD). Human CD4+
lymphocytes express functionally heterogeneous profiles of cytokine production. CD26 is an integral membrane glycoprotein, that is, a marker of Th1-like cytokine development. The purpose of the present study was to compare the immuno-expression of CD26 receptor in periodontal sites with and without clinical attachment loss (CAL). Five patients with rapidly progressing
periodontitis and one with juvenile periodontitis were investigated. Each patient presented at least one site with and without CAL. Ten sites with CAL and nine without any CAL were biopsied, followed by the immunohistochemical identification of the CD26 receptor using the MIB-DS2/7 antibody. The results
demonstrated that the percentage of positive cells for this antigen in the periodontal sites with CAL was not significantly different from those without attachment loss. Therefore, Th1 cell impairment may not be directly involved with periodontal attachment loss.
Patent AT-E400729-T1: [Translated] SELF-REGULATING TURBINE

The turbine set (1) has the gap between the turbine blades widened or narrowed in dependence on the supplied gas or steam quantity and/or the inclination and/or length of the turbine blades adjusted in dependence on the gas or steam temperature or pressure once the required turbine revs is reached, with additional regulation for limiting the turbine revs provided by variation of the current flow in the generator driven by the turbine.  Several turbine sets (1) have a central axial steam or gas entry bore (2) provided with a spring-biased control cylinder (3) regulated in dependence on the temperature and pressure.
Patent AT-E39978-T1: [Translated] SPRING FOR ONE KEY.

In order to save space and manufacturing costs a pull-off effect for the operation of a key should be achieved by using a single spring. Thus the spring must have an arc-like force vs. displacement characteristic having a maximum of force about on half-way of the key stroke. This is achieved by a meander-like shaped spring (1) of flat material having two end loops (2, 3) of equal height and one middle loop (4) of about twice this height, all these loops lying within the same plane. The mounted spring is pretensioned in two directions being perpendicular to each other and lying in said plane, the operating force being applied to the top (7) of the middle loop.
Adapting a Promising Multi-Faceted Child Maltreatment Preventive Intervention to Respond to Differences in Target Populations

A presentation on the use of Washoe County's  SAFE-Family Connections intervention with families with children determined to be unsafe, part of the Nevada Initiative to Reduce Long-Term Foster Care / Permanency Innovations Initiative (PII).

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527702: Butanoic acid, 4-chloro, 2-propynyl ester

Chemical compound data from PubChem database. IUPAC Name: prop-2-ynyl 4-chlorobutanoate. Molecular Formula: C7H9ClO2. Molecular Weight: 160.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400642-T1: [Translated] SOLID CLEANING AGENTS

Solid cleaning products suitable for use as a floor cleaner are disclosed. The solid cleaning products are essentially free of unbound water and include an acid, an anionic surfactant, a nonionic surfactant and a builder. The present invention also discloses methods of using the solid cleaning products by dissolving the solid cleaning product in water to form a use solution; and applying the use solution to a floor.
Patent AT-E399724-T1: [Translated] PACKAGING AND DELIVERY OF CONTACT LENSES

A package is provided for supplying contact lenses directly to a wearer by mail or internet order. An outer mailing envelope ( 402 ) contains packages of bulk quantity of lenses ( 210 ) and a trial quantity of lenses ( 310 ) of the same prescription and manufacturing lot. These are supplied simultaneously, the bulk lenses being packaged with a tamper-evident seal ( 212 ) while the trial lenses are accessible for use without breaking said seal. In the example described, bulk and trial packs of lenses for two eyes are contained within the same mailing envelope. Each bulk pack contains 92 lenses for three months' wear, plus a strip of four lenses in the trial pack. The strip of trial lenses is taken from one of six sheets of sixteen lenses included in the bulk pack. Prescription and lot details can be read directly from the blister packs through window in the bulk package, without breaking the seal ( 212 ).
NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable

NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Data from California published in week 29 for years 2019 and 2020 were incomplete when originally published on July 24, 2020. On August 4, 2020, incomplete case counts were replaced with a "U" indicating case counts are not available for specified time period. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ For acute Hepatitis C, only confirmed cases were verified.
Compound 529738: Methyl 2,2-dichloropentanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 2,2-dichloropentanoate. Molecular Formula: C6H10Cl2O2. Molecular Weight: 185.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528784: Cyclononatriacontasiloxane, octaheptacontamethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28,30,30,32,32,34,34,36,36,38,38,40,40,42,42,44,44,46,46,48,48,50,50,52,52,54,54,56,56,58,58,60,60,62,62,64,64,66,66,68,68,70,70,72,72,74,74,76,76,78,78-octaheptacontamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67,69,71,73,75,77-nonatriacontaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28,30,32,34,36,38,40,42,44,46,48,50,52,54,56,58,60,62,64,66,68,70,72,74,76,78-nonatriacontasilacyclooctaheptacontane. Molecular Formula: C78H234O39Si39. Molecular Weight: 2892.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530309: Methyl 3-phenyl-2-(trifluoroacetamido)propanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 3-phenyl-2-[(2,2,2-trifluoroacetyl)amino]propanoate. Molecular Formula: C12H12F3NO3. Molecular Weight: 275.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Osmotic stress-dependent serine phosphorylation of the histidine kinase homologue DokA

Background
          Two-component systems consisting of histidine kinases and their corresponding receivers are widespread in bacterial signal transduction. In the past few years, genes coding for homologues of two-component systems were also discovered in eukaryotic organisms. DokA, a homologue of bacterial histidine kinases, is an element of the osmoregulatory pathway in the amoeba Dictyostelium. The work described here addresses the question whether DokA is phosphorylated in vivo in response to osmotic stress.
        
        
          Results
          We have endogenously overexpressed individual domains of DokA to investigate post-translational modification of the protein in response to osmotic shock in vivo. Dictyostelium cells were labeled with [32P]-orthophosphate, exposed to osmotic stress and DokA fragments were subsequently isolated by immunoprecipitation. Thus, a stress-dependent phosphorylation could be demonstrated, with the site of phosphorylation being located in the kinase domain. We demonstrate biochemically that the phosphorylated amino acid is serine, and by mutational analysis that the phosphorylation reaction is not due to an autophosphorylation of DokA. Furthermore, mutation of the conserved histidine did not affect the osmostress-dependent phosphorylation reaction.
        
        
          Conclusions
          A stimulus-dependent serine phosphorylation of a eukaryotic histidine kinase homologue was demonstrated for the first time in vivo. That implies that DokA, although showing typical structural features of a bacterial two-component system, might be part of a eukaryotic signal transduction pathway that involves serine/threonine kinases.